MENU
+Compare
RDY
Stock ticker: NYSE
AS OF
Jun 4 closing price
Price
$14.75
Change
+$0.09 (+0.61%)
Capitalization
12.48B

RDY Dr. Reddy's Laboratories Ltd Forecast, Technical & Fundamental Analysis

RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RDY with price predictions
Jun 04, 2025

RDY in upward trend: price rose above 50-day moving average on May 09, 2025

RDY moved above its 50-day moving average on May 09, 2025 date and that indicates a change from a downward trend to an upward trend. In of 48 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 13, 2025. You may want to consider a long position or call options on RDY as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RDY just turned positive on May 14, 2025. Looking at past instances where RDY's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RDY advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .

RDY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 262 cases where RDY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RDY moved out of overbought territory on May 28, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RDY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.833) is normal, around the industry mean (62.170). P/E Ratio (19.682) is within average values for comparable stocks, (89.614). Projected Growth (PEG Ratio) (4.879) is also within normal values, averaging (2.987). Dividend Yield (0.007) settles around the average of (0.122) among similar stocks. P/S Ratio (3.786) is also within normal values, averaging (19.131).

View a ticker or compare two or three
RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RDY is expected to report earnings to fall 6.95% to 20 cents per share on July 24

Dr. Reddy's Laboratories Ltd RDY Stock Earnings Reports
Q2'25
Est.
$0.20
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.03
Q2'24
Beat
by $0.05
The last earnings report on May 09 showed earnings per share of 21 cents, beating the estimate of 20 cents. With 2.18M shares outstanding, the current market capitalization sits at 12.48B.
A.I.Advisor
published Dividends

RDY paid dividends on August 12, 2024

Dr. Reddy's Laboratories Ltd RDY Stock Dividends
А dividend of $4.78 per share was paid with a record date of August 12, 2024, and an ex-dividend date of July 30, 2024. Read more...
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
8-2-337, Road No. 3
Phone
+91 4049002900
Employees
25863
Web
https://www.drreddys.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DGRE26.640.24
+0.89%
WisdomTree Emerging Mkts Qual Div Gr ETF
GLD310.901.99
+0.64%
SPDR® Gold Shares
SDEM26.380.10
+0.39%
Global X MSCI SuperDividend® Em Mkts ETF
TCHP43.360.17
+0.39%
T. Rowe Price Blue Chip Growth ETF
GJAN39.16N/A
N/A
FT Vest U.S. Eq Mod Buffr ETF - Jan

RDY and Stocks

Correlation & Price change

A.I.dvisor tells us that RDY and COLL have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDY and COLL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDY
1D Price
Change %
RDY100%
+0.61%
COLL - RDY
32%
Poorly correlated
+0.58%
KMDA - RDY
29%
Poorly correlated
-1.04%
ZTS - RDY
27%
Poorly correlated
-1.00%
AMPH - RDY
27%
Poorly correlated
+1.89%
TAK - RDY
25%
Poorly correlated
+0.40%
More